X-Therma Inc.
Richmond, CA · CIK 0001893252 · Medtech · Private
XT-ViVo, a novel cryoprotectant formulation for subzero ischemic organ preservation enabling extended cold ischemia time
x-therma.com →- Grants
- $5.8M
- 8 awards
- Sector median: 1
- Raised
- $35M
- 3 Form D · Mar 2024
- 31 months since last filing
- Contracts
- $2.2M
- 3 awards · Defense
- #215 of 4531 in medtech
- Patents
- 25
- 13 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Defense · Phase I · Optimization of Cryoprotectants, Cryotherapeutics, and Protocols for Cryopreservation of Large Tissue Systems | $149,991 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Developing Nanopores to Facilitate Delivery of Intracellular Cryoprotectants for Biopreservation at Low Temperature | $224,995 | |
| Federal grant | Department of Defense · Phase I · Novel Supercooling Protocol for Long-term Storage and Banking of Penile Tissue | $154,635 | |
| Federal contract· 1 of 3 same day | Department of Defense · Army Phase I Proposal A161-050-0642. Igf::ot::igf | $149,441 | |
| Federal contract· 2 of 3 same day | Department of Defense · Igf::ot::igf SBIR Phase II Dhp 15.1 H151-013-0061 | $1,009,938 | |
| Federal grant· 3 of 3 same day | Department of Defense · Phase II · Phase II: Non-toxic, Highly-effective Bioinspired Cryoprotectants | $999,938 | |
| Federal grant | Department of Defense · Phase II · Novel Super-cooling of Genitourinary Cells and Tissues for Transplant | $998,967 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Dynamic Nanopores Enabling Non-toxic Cryopreservation to Advance Centralized Manufacturing & Transport of Regenerative Medicines | $1,243,322 | |
| Federal contract | Department of Defense · Igf::ot::igf Army SBIR Phase II Proposal No. A2-6795 | $999,793 | |
| Private capital raised | Form D · SEC | $10,355,331 | |
| Private capital raised | Form D · SEC | $2,644,669 | |
| Federal grant | Department of Health and Human Services · Phase II · Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants | $971,228 | |
| Private capital raised | Form D · SEC | $22,378,696 | |
| Federal grant | Department of Health and Human Services · Phase II · Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants | $1,015,699 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 212 | Amprion, Inc. | $2.2M | $15M |
| 213 | NeuroPace | $2.2M | $187M |
| 214 | DREAM SYSTEMS, LLC | $2.2M | — |
| 215 | X-Therma Inc. | $2.2M | $35M |
| 216 | FARUS, LLC | $2.1M | — |
| 217 | BIOMEDOMICS, INC. | $2.1M | $1.5M |
| 218 | BASE PAIR BIOTECHNOLOGIES INC | $2.1M | $1.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- James GreenwoodDirector
- Mark KlineDirector · Executive Officer
- Johannes WeggemannDirector · Executive Officer
- Xiaoxi WeiDirector · Executive Officer
Patents
- Organ And Tissue Transport Devicegranted
- Organ And Tissue Transport Devicegranted
- Organ And Tissue Transport Devicegranted
- Compositions And Methods For Reducing Ice Crystal Formationapplication
- Novel Peptoid Polymers And Methods Of Usegranted
- Novel Supercooling Methods For Preservation Of Biological Samplesapplication
- Organ And Tissue Transport Devicegranted
- Novel Supercooling Methods For Preservation Of Biological Samplesgranted
- Compositions And Methods For Reducing Ice Crystal Formationgranted
- Apparatus For Biological Material Storage And Transportapplication
- Apparatus For Biological Material Storage And Transportgranted
- Novel Peptoid Polymers And Methods Of Usegranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.